What antibiotics commonly pair well with tigecycline?

How do clinicians choose antibiotics to combine with tigecycline?

Clinicians combine tigecycline with other agents primarily to cover organisms outside its spectrum or to exploit synergistic effects. Tigecycline covers most gram-positive bacteria, anaerobes, and many gram-negative rods, but has limited activity against Pseudomonas, Proteus, and viruses.

What organisms remain uncovered when tigecycline is used alone?

The gaps include Pseudomonas aeruginosa, Proteus mirabilis, and some indole-positive Proteus species. These organisms show intrinsic resistance to tigecycline because of efflux pumps that expel the drug.

How does synergy affect the choice of companion drugs?

Synergistic combinations widen the spectrum and may reduce required doses. In vitro studies show tigecycline plus colistin or tigecycline plus aminoglycosides demonstrate synergy against carbapenem-resistant Enterobacterales and Pseudomonas.

When does the combination expand coverage to Pseudomonas?

Tigecycline is rarely combined with an antipseudomonal beta-lactam such as ceftazidime, cefepime, or piperacillin-tazobactam to extend coverage to P. aeruginosa.

What side effects are patients asking about when tigecycline is paired with other drugs?

Patients and clinicians track gastrointestinal upset and nausea, which occurs frequently with tigecycline. The combination with colistin adds nephrotoxicity risk.

Why are companies challenging this patent?

Tigecycline’s compound patent expired in the US in 2020. Since then, generic manufacturers have entered the market and generic versions are now widely available.